The Biomaterial R&BD Center (BMC) is a leading institution established to support the entire development-to-commercialization process of bio-health-related products — one of the most promising future industries. Through AAALAC International accreditation, BMC operates as a CRO-based preclinical testing center, offering services for new biomaterial-based medical devices (implants, tissue, bone, and dental applications) and veterinary medical devices. To become global leading biomaterial and medical-device preclinical evaluation center, providing world-class R&BD infrastructure, trusted regulatory support, and innovative translational research for the global bio-health industry.
detail